🕒 Tuesday 17 February 2026 Tue, 17 Feb 2026

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.

Viva Leisure has announced a year-long on-market share buy-back program targeting up to 10% of its issued shares, aiming to capitalise on market volatility and reinforce its strong cash flow outlook.

Elementos Limited has raised $29.5 million through a strategic placement to L1 Capital, strengthening its financial position as it pushes forward with key tin projects in Spain and Tasmania.

Pureprofile Limited has agreed to acquire CRNRSTONE, an established Australian qualitative research firm, for $700,000 in cash, enhancing its market research capabilities and expected to be earnings accretive from year one.

Alma Metals has revealed a robust 2 million tonne copper resource at its Briggs Project in Central Queensland, setting the stage for a major drilling campaign and pre-feasibility study amid a tightening global copper market.

TZ Limited clarifies its debt repayment timeline and progresses trade finance arrangements to support growing Microsoft-related sales, while highlighting its innovative AI-driven security technology.

Whitefield Income Limited reported a robust half-year profit surge and a significant capital raise, maintaining steady dividends amid a cautiously optimistic economic outlook.

Select Harvests Limited has reported a strong FY2025 financial performance with a net profit after tax of $31.8 million and a significant reduction in net debt. The company plans to resume dividend payments in 2026 amid favourable almond market conditions.

Marquee Resources has announced a substantial 69% increase in its Mt Clement (Eastern Hills) inferred mineral resource, now containing 11,000 tonnes of antimony equivalent metal, positioning the project as a key player in Australia's critical minerals landscape.

Cauldron Energy has reported a significant 32% increase in uranium resources at its Yanrey Uranium Project, highlighted by a maiden Mineral Resource Estimate for Manyingee North and an upgraded resource at Manyingee South.

Clever Culture Systems posted a $1.32 million loss for the half year ending December 2025, reflecting a strategic shift and reduced government grants. Despite this, the company strengthened its cash position, repaid government debt, and grew its APAS Independence instrument footprint globally.

Magnetite Mines’ Razorback Iron Ore Project has been granted Major Project Status by the Australian Government, recognising its national economic importance and unlocking enhanced regulatory support for the next three years.

Hydralyte USA has implemented targeted headcount reductions saving around US$25,000 monthly and completed manufacturing runs to resolve supply shortages, replenishing inventory with key distributors to support near-term sales growth.

Kinatico Ltd reports robust H1 FY26 results, driven by a 49.5% surge in SaaS revenue and the launch of its AI-powered Kinatico Compliance platform, significantly broadening its addressable market.

Resolution Minerals has reported final assay results from its 2025 drilling campaign at the Golden Gate prospects in Idaho, revealing extensive near-surface gold mineralisation alongside significant tungsten intercepts. The findings confirm the potential for a large, open-ended gold-tungsten deposit, setting the stage for accelerated exploration in 2026.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

EAU Lithium, backed by Cosmos Exploration, has formalised a negotiation framework with Bolivia’s state lithium company YLB to explore industrial-scale lithium extraction using Vulcan Energy’s innovative technology.

Terra Metals has confirmed a large, high-grade platinum group metals (PGM) sulfide system at its Southwest SW6 Prospect, revealing thick mineralisation open at depth and a compelling new platinum-rich zone. This discovery expands the scale and complexity of the Dante Project’s magmatic system, setting the stage for an ambitious drilling campaign.

AMCIL and AFIC announce a major leadership transition as long-serving CEO Mark Freeman retires, with Alison Gibson appointed to succeed him in July 2026.

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Mark Freeman, the long-serving CEO of Mirrabooka Investments and AFIC, is set to retire at the end of 2026, with Alison Gibson appointed as his successor. Gibson’s return marks a significant leadership transition for these major listed investment companies.

GR Engineering Services has been named preferred contractor for Brightstar Resources’ Laverton Processing Plant, a major 1.5 Mtpa gold facility in Western Australia, pending final investment and funding decisions.